FDA Drug Application (020192) for LAMISIL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020192
Product Number001
FormCREAM;TOPICAL
Dosage1%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMISIL
Active IngredientTERBINAFINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TERBINAFINE2
List of drugs with Active Ingredient TERBINAFINE HYDROCHLORIDE3


Back to FDA Applications sponsored by NOVARTIS